Testimonials

Cheng Chen
February 2018

I learned the concept regarding how to set the starting and miximum doses and how to design the dose escalation. The CMC and preclinical requirement, the design of FIH protocol, determination the dose range for FIH clinical trials. 

Course followed
Katarzyna Jastrzebska
February 2018

It is a good overview on the preclinical study required to enter phase I. Comprehensive overview on CMC and toxicology studies.

Course followed
Liesbet Herteleer
February 2018

Good teacher, clear explanation. Real life examples that made it very clear.

Course followed
Foundational ICH-Good Clinical Practice (GCP) E6 (R2) Training
Company
Roche NV

Pages